Amrad shareholders stock up

By Melissa Trudinger
Thursday, 22 July, 2004

Some of Amrad's larger shareholders are boosting their holdings in the Melbourne company (ASX:AML), as long-time Japanese investor Chugai divests itself of its 10 per cent stake in the company.

Yesterday the Queensland Investment Corporation -- a major institutional player in Australia's biotechnology sector -- filed documents with the ASX indicating that it had increased its holdings from 5.45 per cent to 10.495 per cent.

And today, the Thorney group, run by multi-millionaire Richard Pratt, said it had raised its stake in the company from 9.14 per cent to 11.88 per cent.

Chugai retains a 2.52 per cent share of the company, making $4.3 million out of the sale of its shares.

The relationship between Amrad and Chugai stretches back 10 years, over which time the Japanese company invested about $20 million into Amrad. But the joint research contract came to a natural end last year when its term expired.

Related News

Common arthritis drug also lowers blood pressure

Scientists have known for a while that methotrexate helps with inflammation, but it may also help...

AI enables precise gene editing

A newly developed tool utilises AI to predict how cells repair their DNA after it is cut by gene...

Shingles vaccine may reduce risk of heart attack and stroke 

Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd